At a glance
ClinicalIndex Comparison RecordN/ACompleted· 52 enrolled
Drug / intervention
air filtration with air purifier with hepa filter +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Reducing Particulate Matter-associated Cardiovascular Health Effects for Seniors
In Brief
A clinical study evaluating air filtration with air purifier with hepa filter and sham for Cardiometabolic Health. Completed, enrolled 52 participants across 1 site.
Detailed Summary
Exposure to fine particulate matter (PM2.5) air pollution is an established risk factor for cardiovascular (CV) morbidity.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiometabolic Health
CountriesUnited States
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedSep 2019
Enrollment StartFeb 2020
Primary CompletionNov 2024
TodayJul 2026
First PostedSep 25, 2019
Enrollment StartFeb 24, 2020
Primary CompletionNov 1, 2024
TodayJul 2, 2026
Enrollment to primary: 4.7 yearsPosted 6.8 years ago
Interventions
air filtration with air purifier with hepa filterother
long-term (4 week) air filtration with the Holmes HAP8650B-NU-1 air purifier in the residence of low-income seniors impacted by roadway pollutants.
shamother
air purifier running with air filter removed